Stock Market News

1 day BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer’s Heart DrugInvestor's Business Daily

BridgeBio Pharma snagged FDA approval for its rival to Pfizer’s heart disease treatment, Vyndaqel. BridgeBio stock catapulted.
The post BridgeBio Catapults After Snagging Approval For Its Rival To Pfizer's Heart Drug appeared first on Investor&#03…

Pfizer (PFE)

6 hours Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should KnowZacks X

10 hours 2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive IncomeThe Motley Fool X

4 days Pharma Stock Roundup: EU Nod for PFE’s Hympavzi, NVS Ups Sales ViewZacks X

4 days Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)Seeking Alpha X

5 days Pfizer: High Dividend And Low Price Might Still Offset The Expanding RisksSeeking Alpha X

5 days PFE vs. NVO: Which Stock Is the Better Value Option?Zacks X

5 days The Zacks Analyst Blog Highlights Adobe, Pfizer, Dollar General, Snap and RyanairZacks X

5 days Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EUZacks X

6 days Pfizer names oncology head Chris Boshoff as R&D chiefInvesting.com X

6 days Pfizer names oncology chief and company veteran Boshoff as chief scientific officerMarketWatch X

6 days Pfizer Names New R&D ChiefThe Wall Street Journal X

6 days Is It Time to Sell Eli Lilly and Pfizer Stocks?The Motley Fool X

6 days Is It Time to Sell Eli Lilly and Pfizer Stocks?Yahoo Finance X

7 days Pfizer cannot recoup $75 million from SEC insider trading settlement, judge rulesYahoo Finance X

1 week The Zacks Analyst Blog Highlights Pfizer, Newmont, Uber, Adobe and QualcommZacks X

1 week Jim Cramer on Pfizer Inc. (PFE): ‘Still, Anything Good There, It Could Fly’Insider Monkey X

2 weeks Pfizer- am I stuck with take lock or is this a great value?Reddit X

2 weeks Pfizer (PFE) is a Top-Ranked Value Stock: Should You Buy?Zacks X

2 weeks Moderna, Lily, Novavax, and Pfizer stocks fall after Trump nominates RFK Jr. as health secretaryFast Company X

2 weeks Pfizer, Moderna, BioNTech Take A Beating After Trump Taps Kennedy To Head Up HHSInvestor's Business Daily X

2 weeks Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on ItZacks X

2 weeks Court Hears New York Times Case Against European Commission Over Vaccine DealThe New York Times X

2 weeks Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHSMarketWatch X

2 weeks Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHSCNBC X

2 weeks Is Pfizer Stock A Sell With Vaccine Skeptic Robert F. Kennedy Jr. Tapped To Lead HHS?Investor's Business Daily X

2 weeks Is Pfizer Inc. (PFE) Among The Top Dividend Contenders Right Now?Insider Monkey X

2 weeks The Oncology Bet Is Already Paying Off For PfizerYahoo Finance X

2 weeks Pfizer Inc. (PFE) UBS Global Healthcare Conference (Transcript)Seeking Alpha X

2 weeks Zacks.com featured highlights include StoneCo, Skechers, Pfizer and General MotorsZacks X

2 weeks 3 Stocks Seeing Insider Buys: CNC, PFE, BMYZacks X

2 weeks Exclusive-Pfizer explores sale of hospital drugs unit, sources sayYahoo Finance X

2 weeks Should Value Investors Buy Pfizer (PFE) Stock?Zacks X

2 weeks AbbVie And Pfizer: Q3 Dividend Checkup Post-EarningsSeeking Alpha X

2 weeks Pfizer Inc. (PFE): Among the Best Low Volatility Stocks to Invest In NowInsider Monkey X

3 weeks 3 Reasons Pfizer Looks Like a No-Brainer Buy Right NowThe Motley Fool X

3 weeks PFE or NVO: Which Is the Better Value Stock Right Now?Zacks X

3 weeks 1 Green Flag That’s Also a Red Flag for Pfizer StockThe Motley Fool X

3 weeks Buy, Sell or Hold Pfizer Stock After Q3 Earnings Beat, Guidance Boost?Zacks X

3 weeks Is Pfizer Stock a Bargain for Long-Term Investors?The Motley Fool X

3 weeks This Beaten-Down Stock Just Gave Investors More Good News: Is it a Buy?The Motley Fool X

3 weeks 3 Potential Catalysts That Could Lift Pfizer Stock Before 2025The Motley Fool X

3 weeks Pfizer Is A Good Stock To Buy After The EarningsSeeking Alpha X

4 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X

4 weeks Pfizer Inc. (NYSE:PFE) Director Acquires $28,240.00 in StockMarketBeat X

4 weeks Is Pfizer (NYSE:PFE) a High-Yielding Dividend Stock Worth Buying?Yahoo Finance X

4 weeks Pfizer (NYSE:PFE) Stock Price Down 0.4% – Should You Sell?MarketBeat X

4 weeks Pfizer CEO discusses Q3 earnings, ‘exceptional’ growthYouTube X

4 weeks Zacks Investment Ideas feature highlights: Pfizer, Philip Morris and Tenet HealthcareZacks X

4 weeks 3 Factors That Make Pfizer’s Ultra-High-Yield Dividend Safer Than You Might ThinkThe Motley Fool X

4 weeks Amgen ‘Laser-Focused’ On Its Weight-Loss Shot As New Rival Pfizer Follows, Says CFOInvestor's Business Daily X